(Q54260524)

English

Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

0 references

atrial fibrillation

0 references

0 references

author name string

Bianconi L

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Mennuni M

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

82

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

584-588

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Intravenous digoxin: still the drug of choice for acute termination of atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Treatment of atrial fibrillation in a district general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Efficacy of flecainide for the reversion of acute onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Reversion of atrial fibrillation to sinus rhythm with digitalis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Clinical course of acute atrial fibrillation treated with rapid digitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Atrial flutter in patients treated for atrial fibrillation with propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Identifiers

10.1016/S0002-9149(98)00412-3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54260524&oldid=1371366658"